Owens&Minor Investor Day Presentation Deck

76 Reinvestments and Execution Sustain Topline Organic Growth Patient Direct driving majority of targeted revenue growth $9.2 2019 Proprietary to Owens & Minor, Inc. $8.5 2020 $9.8 2021 $10.0 2022 Revenue ($B) $10.3- $10.4 2023 Guidance >$12B Revenue Target in 2028 2023 Guidance = Guidance provided on November 3rd, 2023 H $12.0B+ 2028 Target Owens M&Minor

View entire presentation